Cheryl Gault
Chief Operating Officer en Rapport Therapeutics, Inc. .
Fortuna: 2 481 $ al 29/02/2024
Perfil
Cheryl Gault holds the position of Chief Operating Officer at Rapport Therapeutics, Inc.
In the past she was Chief Operating Officer at Cyclerion Therapeutics, Inc., VP-Commercial Strategy & New Product Planning at Ironwood Pharmaceuticals, Inc. and Head-Sales & Marketing at Genzyme Corp.
Ms. Gault received an undergraduate degree from Boston College.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
15/06/2023 | 827 ( 0.03% ) | 2 481 $ | 29/02/2024 |
Cargos activos de Cheryl Gault
Empresas | Cargo | Inicio |
---|---|---|
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Chief Operating Officer | 07/09/2023 |
Antiguos cargos conocidos de Cheryl Gault.
Empresas | Cargo | Fin |
---|---|---|
CYCLERION THERAPEUTICS, INC. | Chief Operating Officer | 28/07/2023 |
IRONWOOD PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01/04/2019 |
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Sales & Marketing | - |
Formación de Cheryl Gault.
Boston College | Undergraduate Degree |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 2 |
---|---|
IRONWOOD PHARMACEUTICALS, INC. | Health Technology |
CYCLERION THERAPEUTICS, INC. | Health Technology |
Empresas privadas | 2 |
---|---|
Genzyme Corp.
Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Rapport Therapeutics, Inc.
Rapport Therapeutics, Inc. BiotechnologyHealth Technology Rapport Therapeutics, Inc. is an American clinical-stage biotechnology company that focuses on discovering and developing medicines for neurological disorders. The CEO of the company is Abraham N. Ceesay. | Health Technology |